Clinical Trial Update: PK Study of N91115 in Cystic Fibrosis Patients [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of N91115 in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• N91115

Snippet

Sponsor: Nivalis Therapeutics, Inc. | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED